$PRPH

ProPhase Labs, a biotechnology and diagnostics company, has completed a series of financial and corporate actions, including securing a new equity financing facility of up to $10 million from Generating Alpha Ltd. The company also underwent a 1-for-10 reverse stock split and transitioned its trading from the Nasdaq to the OTC Pink Sheets tier following delisting. These moves, alongside the conversion of over $3.3 million in convertible debt, aim to strengthen the company's liquidity and simplify its capital structure despite continued stock volatility.